Viewing Study NCT02855892

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:42 PM
Ignite Modification Date: 2026-02-05 @ 7:24 AM
Study NCT ID: NCT02855892
Status: COMPLETED
Last Update Posted: 2022-03-04
First Post: 2016-08-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH
Sponsor: GemVax & Kael
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Benign Prostatic Hyperplasia (BPH) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GV1001 View
None BPH View
None Benign prostatic hyperplasia View